Table 2.
IL-12 p40 | IL-10 | |
---|---|---|
Donor 1 | ||
DCs alone | < 4 | < 10 |
DCs + untreated T cells | 4008 | 5260 |
DCs + AT-2 HIV exposed T cells | 1755 | 2172 |
DCs + AT-2 HIV exposed T cells + 1 μg/mL rCD154 | 4725 | 6458 |
DCs + AT-2 HIV exposed T cells + 2.5 μg/mL rCD154 | 5118 | 6942 |
DCs + AT-2 HIV exposed T cells + 5 μg/mL rCD154 | 5154 | 7091 |
Donor 2 | ||
DCs alone | < 4 | < 10 |
DCs + untreated T cells | 3013 | 539 |
DCs + AT-2 HIV exposed T cells | 1400 | 93 |
DCs + AT-2 HIV exposed T cells + 0.5 μg/mL rCD154 | 2246 | 633 |
DCs + AT-2 HIV exposed T cells + 1 μg/mL rCD154 | 4050 | 1141 |
DCs + AT-2 HIV exposed T cells + 2.5 μg/mL rCD154 | 4018 | 2098 |
DCs + AT-2 HIV exposed T cells + 5 μg/mL rCD154 | 4461 | 3644 |
Purified CD4+ T cells from 2 individuals were stimulated with anti-CD3/CD28 beads, in the presence of AT-2 HIV (AT-2—exposed T cells) or in the absence of AT-2 HIV (untreated), as described in Figure 1. After several washes, T cells were cultured with autologous DCs in the absence or presence of graded doses of rCD154 (0.5-5 μg/mL). Production of IL-12 p40 and IL-10 (expressed in pg/mL) was analyzed as described in the legend of Figure 1.